From basic ovarian physiology to ovarian stimulation

The lecture by Human M. Fatemi addresses why, in clinical practice, a patient's age is far from a reliable predictor of how her ovaries will respond to stimulation, and what the reproductive specialist should assess beyond the date of birth. Building on the basic physiology of folliculogenesis, the speaker bridges the fundamental mechanisms of ovarian function and the rational choice of a controlled ovarian stimulation protocol.

The account rests on the premise that ovarian response is shaped by a combination of factors rather than by chronological age alone. The primordial follicle pool, the sensitivity of granulosa cells to gonadotropins, the state of the FSH and LH receptor apparatus, and the underlying endocrine and metabolic setting jointly determine how many antral follicles can be recruited and carried through to a mature oocyte.

From this follows the central clinical paradox that occupies much of the lecture: a young woman may turn out to be a poor responder, while an older patient may retain an unexpectedly high reserve. The chronological and biological age of the ovary diverge, and relying on year of birth alone leads either to an insufficient or to an excessive gonadotropin dose and a higher risk of complications.

To avoid this error, the speaker argues for a multifactorial approach to ovarian reserve assessment. This means interpreting anti-Mullerian hormone and antral follicle count together as complementary markers, framed by clinical context — the history of previous cycles, prior gynecological interventions, body mass index, and comorbidities. No single parameter is a sufficient basis for a decision on its own.

At the physiological level, the lecture recalls the two-cell, two-gonadotropin model of steroidogenesis, in which LH drives androgen production in theca cells while FSH ensures their aromatization to estrogens in granulosa cells. Understanding this mechanism explains why, in a subset of patients, adequate follicular growth requires not only FSH but also sufficient LH activity, and it sets the basis for differentiated prescribing.